Evidence map›Paper›PMID 41688446›Full record

ArticleNature communications2026

RiboBright reveals cell-type-specific differences in ribosome organization and movement.

Georgia Poulladofonou, Carmen Grandi, Xinyu Hu, Phillip Yesley, Willem A Velema, Maike M K Hansen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Georgia Poulladofonou *Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands.ORCID http://orcid.org/0009-0008-3381-5851
Carmen Grandi *Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-1323-4140
Xinyu Hu *Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-9211-1765
Phillip YesleyInstitute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands.
Willem A VelemaInstitute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands. willem.velema@ru.nl.ORCID http://orcid.org/0000-0003-0257-2734
Maike M K HansenInstitute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands. maike.hansen@ru.nl.ORCID http://orcid.org/0000-0001-7998-6631

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101041939
6 · The paper itself

Abstract

Ribosomes are responsible for protein synthesis in all living systems. Determining their cellular organization, movement, and translational activity is crucial for dissecting ribosomes' complex functions. In this study, we describe the development of a selective fluorescent probe for eukaryotic ribosomes - RiboBright. Using C-H activation, the natural product cycloheximide was aminated at the C13-position and fluorescently modified to afford RiboBright. We employ RiboBright for the quantification of ribosome content in 10 cell lines through microscopy and flow cytometry. RiboBright is applicable in live cells for tracking and quantification of ribosome movement and in fixed cells for visualization of sub-micrometer-sized spots, at the single-cell level. RiboBright reveals lineage-specific ribosome content, organization, and movement upon differentiation into either extraembryonic endoderm or ectoderm-like cells. Thus, RiboBright provides a versatile and convenient approach for imaging the cellular dynamics of ribosomes.

Indexed as

Fluorescent DyesRibosomesAnimalsCell DifferentiationCell LineCycloheximideFlow CytometryHumansProtein BiosynthesisCycloheximideFluorescent Dyes

Identifiers

PMID41688446
PMCPMC13013698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.